Pds biotech appoints lars boesgaard as chief financial officer

Princeton, n.j., nov. 28, 2023 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (“pds biotech” or the “company”), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the company's proprietary t cell activating platforms, today announced the appointment of lars boesgaard as chief financial officer (cfo), effective as of december 4, 2023. mr. boesgaard succeeds matthew hill, who resigned as pds biotech's cfo on november 21, 2023, effective december 1, 2023, to pursue other professional endeavors.
PDSB Ratings Summary
PDSB Quant Ranking